These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36918912)

  • 1. MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR.
    Chaudhary S; Appadurai MI; Maurya SK; Nallasamy P; Marimuthu S; Shah A; Atri P; Ramakanth CV; Lele SM; Seshacharyulu P; Ponnusamy MP; Nasser MW; Ganti AK; Batra SK; Lakshmanan I
    Breast Cancer Res; 2023 Mar; 25(1):25. PubMed ID: 36918912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer.
    Xia L; Wang H
    Breast J; 2022; 2022():7689718. PubMed ID: 35711895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.
    Lakshmanan I; Salfity S; Seshacharyulu P; Rachagani S; Thomas A; Das S; Majhi PD; Nimmakayala RK; Vengoji R; Lele SM; Ponnusamy MP; Batra SK; Ganti AK
    Clin Cancer Res; 2017 Jul; 23(14):3906-3917. PubMed ID: 28196872
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
    Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
    Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) Cells.
    Umar SM; Patra S; Kashyap A; Dev J R A; Kumar L; Prasad CP
    Nutr Cancer; 2022; 74(4):1497-1510. PubMed ID: 34278888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
    Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
    Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
    Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
    Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion.
    Marimuthu S; Lakshmanan I; Muniyan S; Gautam SK; Nimmakayala RK; Rauth S; Atri P; Shah A; Bhyravbhatla N; Mallya K; Grandgenett PM; Hollingsworth MA; Datta K; Jain M; Ponnusamy MP; Batra SK
    Mol Cancer Res; 2022 Aug; 20(8):1208-1221. PubMed ID: 35533267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.
    Gagliardi M; Pitner MK; Park J; Xie X; Saso H; Larson RA; Sammons RM; Chen H; Wei C; Masuda H; Chauhan G; Kondo K; Tripathy D; Ueno NT; Dalby KN; Debeb BG; Bartholomeusz C
    Sci Rep; 2020 May; 10(1):8537. PubMed ID: 32444778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
    Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
    Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
    Zeng X; Ma X; Guo H; Wei L; Zhang Y; Sun C; Han N; Sun S; Zhang N
    Bioengineered; 2021 Dec; 12(2):10126-10135. PubMed ID: 34978519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression.
    Kuo WH; Chu PY; Wang CC; Huang PS; Chan SH
    Biol Direct; 2023 Aug; 18(1):44. PubMed ID: 37550720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
    Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
    Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
    [No Abstract]   [Full Text] [Related]  

  • 18. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
    Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
    Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.